Search Results - "Butuca, Anca"

Osilodrostat Safety Profile: Findings from Real-World Data in the FAERS Database.

Authors: Popa Ilie, Ioana Rada Butuca, Anca Homorodean, Calin et al.

Source: Journal of Clinical Medicine. May2025, Vol. 14 Issue 10, p3518. 20p.

Inefficiency Rates of Biological Immunosuppressive Induction Agents Used in Organ Transplantation: A Pharmacovigilance Study.

Authors: Butuca, Anca Stoicescu, Laurentiu Popa, Mirela Livia et al.

Source: Journal of Clinical Medicine. May2025, Vol. 14 Issue 10, p3409. 17p.

Bevacizumab—Insights from EudraVigilance Database on the Assessments of the Safety Profile of Monoclonal Antibodies Used as Targeted Cancer Treatment.

Authors: Vonica, Razvan Constantin Butuca, Anca Morgovan, Claudiu et al.

Source: Pharmaceuticals (14248247). Apr2025, Vol. 18 Issue 4, p501. 22p.

Systemic Inflammation and Survival in Stage IV Colorectal Cancer: A Retrospective Cohort Study.

Authors: Vonica, Razvan Constantin Palade, Nastaca Alina Butuca, Anca et al.

Source: Journal of Clinical Medicine. Mar2026, Vol. 15 Issue 6, p2319. 18p.

Contributions of Pharmacovigilance to the Understanding of Risks Associated with Ibuprofen: Descriptive and Disproportionality Analysis Using FAERS Data.

Authors: Buciuman, Cristina Anamaria Dobrea, Carmen Maximiliana Butuca, Anca et al.

Source: Pharmaceuticals (14248247). Feb2026, Vol. 19 Issue 2, p319. 16p.

The Descriptive and Disproportionality Assessment of EudraVigilance Database Reports on Capecitabine Induced Cardiotoxicity.

Authors: Vonica, Razvan Constantin Butuca, Anca Vonica-Tincu, Andreea Loredana et al.

Source: Cancers. Nov2024, Vol. 16 Issue 22, p3847. 22p.

Resistance, Ineffectiveness, and Off-Label Use Related to Cephalosporins from the Reserve Group—A Pharmacovigilance Signal Detection Study on EudraVigilance Database.

Authors: Arseniu, Anca Maria Vintila, Bogdan Ioan Butuca, Anca et al.

Source: Pharmaceuticals (14248247). Jan2026, Vol. 19 Issue 1, p155. 21p.

hs-CRP/HDL Ratio Across Obesity and Type 2 Diabetes Mellitus Phenotypes in Adults: A Cross-Sectional Study.

Authors: Solomon, Crina Cristina Palade, Nastaca Alina Gligor, Felicia Gabriela et al.

Source: Diagnostics (2075-4418). Jul2026, Vol. 16 Issue 13, p2013. 17p.

Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data.

Authors: Popa Ilie, Ioana Rada Ghibu, Steliana Butuca, Anca et al.

Source: Pharmaceuticals (14248247). Jun2026, Vol. 19 Issue 6, p876. 23p.

Pharmacovigilance Insights into Ibuprofen's Neuropsychiatric Safety: A Retrospective Analysis of EudraVigilance Reports.

Authors: Buciuman, Cristina Anamaria Dobrea, Carmen Maximiliana Butuca, Anca et al.

Source: Pharmaceuticals (14248247). Sep2025, Vol. 18 Issue 9, p1301. 21p.

Determination of Zn 2+ in Solid Pharmaceutical Dosage Forms by Means of Spectrophotometry in Micellar Media: Method Validation.

Authors: Rus, Luca Liviu Juncan, Anca Maria Crăciun, Veronica Isabela et al.

Source: Applied Sciences (2076-3417); May2022, Vol. 12 Issue 9, pN.PAG-N.PAG, 12p

Exploring the Cardiovascular Safety Profile of Ibuprofen: Insights from EudraVigilance Database.

Authors: Buciuman, Cristina Anamaria Dobrea, Carmen Maximiliana Butuca, Anca et al.

Source: Pharmaceuticals (14248247). Jul2025, Vol. 18 Issue 7, p1045. 18p.

Neuropsychiatric Burden of SARS-CoV-2: A Review of Its Physiopathology, Underlying Mechanisms, and Management Strategies.

Authors: Pacnejer, Aliteia-Maria Butuca, Anca Dobrea, Carmen Maximiliana et al.

Source: Viruses (1999-4915). Dec2024, Vol. 16 Issue 12, p1811. 26p.

Real-World Evidence of Bevacizumab and Panitumumab Drug Resistance and Drug Ineffectiveness from EudraVigilance Database.

Authors: Vonica, Razvan Constantin Morgovan, Claudiu Butuca, Anca et al.

Source: Cancers. Feb2025, Vol. 17 Issue 4, p663. 21p.

Drug–Drug Interactions of Selective Serotonin Reuptake Inhibitors: A Pharmacovigilance Study on Real-World Evidence from the EudraVigilance Database.

Authors: Dobrea, Carmen Maximiliana Frum, Adina Butuca, Anca et al.

Source: Pharmaceuticals (14248247). Oct2024, Vol. 17 Issue 10, p1278. 16p.

An Overview of Anticoagulant Drugs Pharmacology, Therapeutic Approaches, Limitations and Perspectives.

Authors: Morgovan, Claudiu Frum, Adina Stoicescu, Laurentiu et al.

Source: Pharmaceutics. Feb2026, Vol. 18 Issue 2, p163. 53p.

The Efficacy and Safety of Anlotinib in the Treatment of Thyroid Cancer: A Systematic Review.

Authors: Muntean, Calin Solomon, Adelaida Cipaian, Remus Calin et al.

Source: Journal of Clinical Medicine. Jan2025, Vol. 14 Issue 2, p338. 13p.

Real-Life Data on the Safety of Pasireotide in Acromegaly: Insights from EudraVigilance.

Authors: Popa Ilie, Ioana Rada Dobrea, Carmen Maximiliana Butuca, Anca et al.

Source: Pharmaceuticals (14248247). Dec2024, Vol. 17 Issue 12, p1631. 22p.

A Pharmacovigilance Study Regarding the Risk of Antibiotic-Associated Clostridioides difficile Infection Based on Reports from the EudraVigilance Database: Analysis of Some of the Most Used Antibiotics in Intensive Care Units.

Authors: Vintila, Bogdan Ioan Arseniu, Anca Maria Morgovan, Claudiu et al.

Source: Pharmaceuticals (14248247). Nov2023, Vol. 16 Issue 11, p1585. 16p.

Comparative Analysis of Neuropsychiatric Adverse Reactions Associated with Remdesivir and Nirmatrelvir/Ritonavir in COVID-19 Treatment: Insights from EudraVigilance Data.

Authors: Pacnejer, Aliteia-Maria Negru, Mihaela Cristina Arseniu, Anca Maria et al.

Source: Journal of Clinical Medicine. Mar2025, Vol. 14 Issue 6, p1886. 27p.